Varilrix Chickenpox Vaccine Vial - 0.5 mL, Live Attenuated Varicella-Zoster Viru

Varilrix Chickenpox Vaccine Vial

Introducing the Varilrix Chickenpox Vaccine Vial, a live attenuated varicella-zoster virus vaccine designed for effective immunization against chickenpox. This vaccine is formulated with the Oka strain of the virus, ensuring a robust immune response. The vaccine is provided as a lyophilized powder in a monodose vial, accompanied by a separate diluent for reconstitution.

Key Features

• Live attenuated varicella-zoster virus (Oka strain)
• 0.5 mL reconstituted dose
• Includes lactose, mannitol, sorbitol, and neomycin

Technical Specifications

• Form Lyophilized powder for injection
• Strength Not less than 103.3 plaque-forming units per 0.5 mL
• Storage 2 to 8°C

Application

Suitable for active immunization against varicella in healthy individuals aged 12 months and older, as well as high-risk patients and their close contacts.

Typical User/Industry Profile

Healthcare providers, pediatricians, and immunization clinics.

About the Brand

GSK Varilrix is a trusted name in the field of vaccines, known for its innovation and commitment to public health. The brand has pioneered the development of effective vaccines for various infectious diseases, ensuring safety and efficacy.